Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 USD | +5.53% | +9.05% | -66.91% |
04-29 | Immix Biopharma Gets Orphan Drug Label in Europe For Multiple Myeloma Treatment | MT |
04-18 | Immix Biopharma on Track to Dose First Patients with AL Amyloidosis Therapy by Mid-Year | MT |
- Stock Market
- Equities
- IMMX Stock
- News Immix Biopharma, Inc.